We invest in companies involved in plant-based medical, wellness and industrial applications, notably cannabis and hemp

A unique exposure

With a diversified portfolio of private cannabis and plant-based companies, we offer an exposure to a crisis-resilient market with clear structural growth.

 

A new era of health and wellness

We invest in companies that aim to improve the quality of life for millions of patients, while generating attractive financial returns for our investors.

 

Insights

Over the past three years, we have built an unprecedented network and deep understanding of the nascent industry in Europe, including  its complex regulatory nuances. We know which segments and companies are primed for long term growth.

 

European access

We provide investors with exposure to a diversified portfolio of European cannabis and plant-based companies, which today remain largely private due to the early growth stage of the industry. With strong legislative tailwinds spilling over from North America, the European plant-based health and wellness market is just getting started.

If the evolution of legal cannabis sales were compared to a football match, Canada would be playing its second half, the US its first half, and Europe would about to walk onto the pitch.

Management team

David Bonnier

Co-founder and CEO

David Bonnier

Co-founder and CEO

● Education – University of Colorado at Boulder; BSc in Journalism & Broadcasting
● Experience – +20 years of Investment Management and Banking; Partner at Brummer & Partners, VP at Deutsche Bank
● Other commitments – Board member at Amidea Sweden AB; Board member at Nordic Range AB.

Amaury de Poret

Co-Founder & COO

Amaury de Poret

Co-Founder & COO

● Education – University of Fribourg; LL.B. & Geneva Bar; Fully Qualified Attorney
● Experience – +20 years of Private Equity experience in Legal Advisory and Investment Management
● Other commitments – Co-founder and Investment Advisor at Nasdaq-listed investment company NAXS AB (publ); Board member at Nasdaq First North-listed Flat Capital AB (publ)

Gösta Lundgren

CFO

Gösta Lundgren

CFO

● Education – Uppsala University; LL.M. & BSc in Economics
● Experience – +28 years of consulting CFO-roles at companies within finance, private equity, pharmaceutical etc. with international and public market experience
● Other commitments – currently CFO of the Nasdaq-listed investment company NAXS AB (publ)

Board of Directors

Per Björkman

Chairman

Per Björkman

Chairman

● Education – European University; BBA & Insead; Executive Program
● Experience – +15 years of Board Experience; CEO, Director, and Operative Experience in the Cannabis Industry; previously CEO of leading US cannabis producer
● Other commitments –Director of Business Development at SHL Healthcare AB, Board member at Ramundberget Alpina AB, Offerator AB and US-based Nasdaq-listed SPAC in the cannabis industry,

Dr. Sandra Schoenes

Board Member

Dr. Sandra Schoenes

Board Member

● Education – University of Zurich; MD in Medicine, Dr. in Nuclear Medicine & IESE Business School; MBA
● Experience – +10 years of Medical Cannabis Research; Consulting for various leading European Cannabis Companies
● Other commitments – Senior Consultant and Manager at Executive Insight; Co-founder and Board member at Reyos

Alexandra De Wever Treschow

Board Member

Alexandra De Wever Treschow

Board Member

● Education – Karolinska Institutet; PhD in Medicine, Quantic School of Business and Technology; Executive MBA & MSc in Biomedicine; Lunds Universitet
● Experience – +15 years of Life Science and Consulting; currently CEO of Aprovix AB
● Other commitments – Co-owner and Managing Partner at inRikta Analys AB (Health Care Consulting) and co-founder of IM Care AB (data-driven service provider to the Swedish health care sector

Amaury de Poret

Co-Founder & COO

Amaury de Poret

Co-Founder & COO

● Education – University of Fribourg; LL.B. & Geneva Bar; Fully Qualified Attorney
● Experience – +20 years of Private Equity experience in Legal Advisory and Investment Management
● Other commitments – Co-founder and Investment Advisor at Nasdaq-listed investment company NAXS AB (publ); Board member at Nasdaq First North-listed Flat Capital AB (publ)

To the companies we invest in

  • We offer long term capital: we want you to run your business, without feeling pressured for a fast-track exit.
  • We help out with our network and experience, when and if needed.

Our process

  • We look for segment leaders or early-stage companies that look to fill new gaps in the market.
  • We look for founders with experience, passion and commitment.
  • Our due diligence process allows us to move fast while keeping risks in check.

To Enexis shareholders.

  • We are long-term investors: we believe the European cannabis and plant based sector is the early stages of a multi-decade structural growth cycle; therefore we invest for the long-run, and we hope you do too.   
  • We take risks: the European cannabis and plant-based landscape is young; the vast majority of companies in the sector are in the early growth stage of their cycle, meaning they are dependent on access to capital. And while legislative tailwinds are clear, the mechanics of implementing new laws take time.
  • We are fully aligned with you: we have invested a substantial amount of our own money in the company and we are incentivised by return on investments, not management fees